SEC Form 4 · accession 0000904454-15-000276
CoLucid Pharmaceuticals, Inc. · CLCD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
Jesse I Treu
Director · 10% Owner
Period of report
May 5, 2015
Accepted (ET)
May 7, 2015 · 8:22 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001348649
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $10.00 | May 5, 2015 | A | 5,954 | A | — | May 5, 2025 | Common Stock | 5,954 | 5,954 | D |
Explanation of responses
- F1The options vest in full immediately prior to the start of the Issuer's first annual meeting of stockholders following May 5, 2015.